Zobrazeno 1 - 10
of 3 115
pro vyhledávání: '"GASTROINTESTINAL TOXICITY"'
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-12 (2024)
Abstract The most widely used cancer therapy is radiation therapy, but radiation damage to healthy tissues, particularly the gastrointestinal (GI) system, frequently reduces its effectiveness. This study investigates whether etoricoxib-loaded nanostr
Externí odkaz:
https://doaj.org/article/16c2ed46eb4c4412ad4111eb0672c0e4
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 14, Iss 7, Pp 3281-3285 (2024)
Externí odkaz:
https://doaj.org/article/f7e62766042f4a9bb792be74cbcda4cd
Autor:
A. S. Zhiryakova, N. P. Denisenko, A. V. Kryukov, K. A. Akmalova, S. N. Tuchkova, K. B. Mirzaev, D. A. Sychev
Publikováno v:
Безопасность и риск фармакотерапии, Vol 12, Iss 2, Pp 178-189 (2024)
INTRODUCTION. The variability in patient response to non-steroidal anti-inflammatory drugs (NSAIDs) may be due to genetic polymorphisms. Decreased-function or non-functional CYP2C9 alleles are known to be significant contributors to response variabil
Externí odkaz:
https://doaj.org/article/ce69b2b2c49b44658781ec122244b276
Autor:
Gong Li, Li-Juan Xia, Ya-Qing Shu, Lei Wan, Qiao Huang, Xiao-Yu Ma, Hai-Yi Zhang, Zi-Jian Zheng, Xi-Ran Wang, Shi-Ying Zhou, Ang Gao, Hao Ren, Xin-Lei Lian, Dan Xu, Sheng-Qiu Tang, Xiao-Ping Liao, Wei Qiu, Jian Sun
Publikováno v:
Microbiology Spectrum, Vol 12, Iss 8 (2024)
ABSTRACT Mycophenolate mofetil (MMF) is commonly utilized for the treatment of neuromyelitis optica spectrum disorders (NMOSD). However, a subset of patients experience significant gastrointestinal (GI) adverse effects following MMF administration. T
Externí odkaz:
https://doaj.org/article/c1f32be5bd434d38a2b8390a4c2008ed
Publikováno v:
South African Journal of Oncology, Vol 8, Iss 0, Pp e1-e9 (2024)
Background: Hypofractionated radiotherapy (HFRT) in the treatment of prostate cancer (PCa) has logistical and cost advantages, especially in a resource constrained setting. Studies have demonstrated equivalent efficacy with HFRT schedules using Inten
Externí odkaz:
https://doaj.org/article/efe5839de3954fd88eb245880f734899
Publikováno v:
Case Reports in Oncology, Vol 17, Iss 1, Pp 191-201 (2024)
Introduction: Encorafenib and binimetinib, a combination of BRAF and MEK inhibitors, is a standard of care for patients with advanced BRAFV600-mutant melanoma. This combination is known to have gastrointestinal side effects, most of which are mild an
Externí odkaz:
https://doaj.org/article/730bae2cc2414a7a9577e3a63f48ad8b
Autor:
Fenfang Yue, Xiangdi Zeng, Yufan Wang, Yilin Fang, Mengyun Yue, Xuanqi Zhao, Ruizhe Zhu, Qingwei Zeng, Jing Wei, Tingtao Chen
Publikováno v:
BMC Microbiology, Vol 24, Iss 1, Pp 1-14 (2024)
Abstract Background Colorectal cancer (CRC) is a prevalent malignant malignancy affecting the gastrointestinal tract that is usually treated clinically with chemotherapeutic agents, whereas chemotherapeutic agents can cause severe gastrointestinal to
Externí odkaz:
https://doaj.org/article/364c88e8e58e49d28347b0b7d79c548f
Publikováno v:
BioMedInformatics, Vol 4, Iss 1, Pp 158-172 (2024)
Radiation-induced gastrointestinal (GI) dose constraints are still a matter of concern with the ongoing evolution of patient outcomes and treatment-related toxicity in the era of image-guided intensity-modulated radiation therapy (IMRT), stereotactic
Externí odkaz:
https://doaj.org/article/00e535345e1a41bea1738cfc534f715d
Autor:
O. Gómez-Escudero
Publikováno v:
Revista de Gastroenterología de México, Vol 89, Iss 1, Pp 89-105 (2024)
Resumen: Los nuevos tratamientos oncológicos, particularmente la inmunoterapia (IT) han venido a revolucionar el tratamiento de neoplasias malignas en estadios avanzados. Los inhibidores de los puntos de control son la principal forma de IT y actúa
Externí odkaz:
https://doaj.org/article/b485b597f1fa4b35a14cb24ddad27509